未登录
分享
收藏
分享
收藏Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
Tsukihara, Hiroshi; Nakagawa, Fumio; Sakamoto, Kazuki; Ishida, Keiji; Tanaka, Nozomu; Okabe, Hiroyuki; Uchida, Junji; Matsuo, Kenichi; Takechi, Teiji
分享
收藏Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models
Tanaka, Nozomu; Sakamoto, Kazuki; Okabe, Hiroyuki; Fujioka, Akio; Yamamura, Keisuke; Nakagawa, Fumio; Nagase, Hideki; Yokogawa, Tatsushi; Oguchi, Kei; Ishida, Keiji; Osada, Akiko; Kazuno, Hiromi; Yamada, Yuikari; Matsuo, Kenichi
分享
收藏Trifluorothymidine Incorporation into DNA is the Primary Mechanism of Action of TAS-102, and Leads to Markedly Prolonged Survival in a Mouse Model
Tanaka, N.; Fujioka, A.; Yamamura, K.; Suzuki, T.; Oguchi, K.; Ishida, K.; Sakamoto, K.; Okabe, H.; Matsuo, K.; Utsugi, T.
分享
收藏
分享
收藏New 2-Aryl-1,4-naphthoquinone-1-oxime Methyl Ether Compound Induces Microtubule Depolymerization and Subsequent Apoptosis
Sato, Hiromi; Yamada, Ryota; Yanagihara, Midori; Okuzawa, Hiroko; Iwata, Hiroki; Kurosawa, Ayako; Ichinomiya, Saki; Suzuki, Rina; Okabe, Hiroyuki; Yano, Tomohiro; Kumamoto, Takuya; Suzuki, Noriyuki; Ishikawa, Tsutomu; Ueno, Koichi
分享
收藏
分享
收藏